1. Home
  2. GLOB vs BIO Comparison

GLOB vs BIO Comparison

Compare GLOB & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globant S.A.

GLOB

Globant S.A.

HOLD

Current Price

$65.70

Market Cap

4.7B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$302.43

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLOB
BIO
Founded
2003
1952
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
8.2B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
GLOB
BIO
Price
$65.70
$302.43
Analyst Decision
Buy
Strong Buy
Analyst Count
14
4
Target Price
$95.71
$358.50
AVG Volume (30 Days)
1.1M
156.8K
Earning Date
02-19-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.19
N/A
Revenue
$2,484,891,000.00
$2,557,500,000.00
Revenue This Year
$3.37
$1.62
Revenue Next Year
$1.84
$2.26
P/E Ratio
$30.31
N/A
Revenue Growth
5.56
N/A
52 Week Low
$54.36
$211.43
52 Week High
$228.98
$373.69

Technical Indicators

Market Signals
Indicator
GLOB
BIO
Relative Strength Index (RSI) 47.30 43.61
Support Level $66.10 $298.78
Resistance Level $68.45 $305.62
Average True Range (ATR) 2.30 7.17
MACD -0.45 -0.18
Stochastic Oscillator 1.70 31.12

Price Performance

Historical Comparison
GLOB
BIO

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: